Ocular Therapeutix (OCUL) Liabilities and Shareholders Equity (2013 - 2026)
Ocular Therapeutix's Liabilities and Shareholders Equity came in at $671.32 million for Q2 2026, up 48.7% from $451.33 million a year earlier but down 8.4% from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends
At the end of FY2025, Ocular Therapeutix's Liabilities and Shareholders Equity was $808.06 million, up 76.5% from FY2024.
- Liabilities and Shareholders Equity has increased in each of the last three years, with a five-year compound annual growth rate of 25.3% (FY2020 to FY2025).
- Going back by year, Liabilities and Shareholders Equity was $457.94 million in FY2024 (+81.7%), $252.06 million in FY2023 (+68.8%), $149.29 million in FY2022 (-27.1%) and $204.89 million in FY2021 (-21.8%).
- The five-year range for quarterly Liabilities and Shareholders Equity is $122.56 million (Q2 2023) to $808.06 million (Q4 2025).
- Year-over-year, Liabilities and Shareholders Equity has increased for three consecutive quarters, with growth averaging 54.5% over the last eight quarters.
- The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q2 2024 (growth of 321.9%), and the weakest in Q1 2023 (a decline of 31.5%).
- Business Quant data shows OCUL's Liabilities and Shareholders Equity at $732.53 million (Q1 2026), $808.06 million (Q4 2025) and $410.88 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn | 671.32 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 671.32 Mn |
| Mar 31, 2026 | 732.53 Mn |
| Dec 31, 2025 | 808.06 Mn |
| Sep 30, 2025 | 410.88 Mn |
| Jun 30, 2025 | 451.33 Mn |
| Mar 31, 2025 | 405.92 Mn |
| Dec 31, 2024 | 457.94 Mn |
| Sep 30, 2024 | 490.37 Mn |
| Jun 30, 2024 | 517.09 Mn |
| Mar 31, 2024 | 538.95 Mn |
| Dec 31, 2023 | 252.06 Mn |
| Sep 30, 2023 | 162.38 Mn |
| Jun 30, 2023 | 122.56 Mn |
| Mar 31, 2023 | 128.57 Mn |
| Dec 31, 2022 | 149.29 Mn |
| Sep 30, 2022 | 158.58 Mn |
| Jun 30, 2022 | 173.07 Mn |
| Mar 31, 2022 | 187.62 Mn |
| Dec 31, 2021 | 204.89 Mn |
| Sep 30, 2021 | 217.74 Mn |
API Access
Ocular Therapeutix Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();